Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-05

FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydroxychloroquine sulfate from Sun Pharmaceutical Industries, Inc., updating the approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

SUPPL AP for HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)